# Efficacy of amlodipine as an adjunct to iron chelation therapy in reducing iron overload in thalassemia patients: a systematic review and meta-analysis

Source: [Medical research : nature.com subject feeds](https://www.nature.com/articles/s41598-026-70365-0) · 2026-11-15 · Medicine
Page: https://themorning.science/story/efficacy-of-amlodipine-as-an-adjunct-to-iron-chelation-therapy-in-reducing-iron-5dec840a5499caf7
Kind: research · Impact: low

## In brief

- A systematic review and meta-analysis assesses amlodipine as an adjunct to iron chelation therapy in thalassaemia patients.
- The study's stated aim is reducing iron overload in these patients.
- The headline reports that the review finds amlodipine may aid iron chelation, but the source provides no further results.

## Why it matters

Iron overload is a long-term complication for many thalassaemia patients, so a possible add-on to existing chelation therapy is of interest to clinicians and researchers, though the available source gives no detailed findings.

## Coverage

- [Efficacy of amlodipine as an adjunct to iron chelation therapy in reducing iron overload in thalassemia patients: a systematic review and meta-analysis](https://www.nature.com/articles/s41598-026-70365-0) — Medical research : nature.com subject feeds, 2026-11-15

Tags: thalassaemia, iron overload, chelation therapy, amlodipine, meta-analysis

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science